Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA SUVEN LIFE SCIENCES AJANTA PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 23.8 -14.7 - View Chart
P/BV x 4.9 14.3 34.4% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 AJANTA PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
SUVEN LIFE SCIENCES
Mar-22
AJANTA PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,614124 1,297.6%   
Low Rs1,08970 1,545.3%   
Sales per share (Unadj.) Rs391.10.8 48,008.9%  
Earnings per share (Unadj.) Rs83.4-8.4 -994.3%  
Cash flow per share (Unadj.) Rs98.1-8.1 -1,212.7%  
Dividends per share (Unadj.) Rs9.500-  
Avg Dividend yield %0.70-  
Book value per share (Unadj.) Rs382.16.6 5,778.0%  
Shares outstanding (eoy) m85.42145.38 58.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.5119.6 2.9%   
Avg P/E ratio x16.2-11.6 -139.5%  
P/CF ratio (eoy) x13.8-12.0 -114.4%  
Price / Book Value ratio x3.514.7 24.0%  
Dividend payout %11.40-   
Avg Mkt Cap Rs m115,43314,164 815.0%   
No. of employees `000NANA-   
Total wages/salary Rs m6,458210 3,072.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,410118 28,208.3%  
Other income Rs m1,15753 2,175.7%   
Total revenues Rs m34,567172 20,142.6%   
Gross profit Rs m9,293-1,222 -760.2%  
Depreciation Rs m1,25344 2,852.0%   
Interest Rs m1027 1,522.4%   
Profit before tax Rs m9,095-1,220 -745.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9680-   
Profit after tax Rs m7,127-1,220 -584.2%  
Gross profit margin %27.8-1,032.2 -2.7%  
Effective tax rate %21.60-   
Net profit margin %21.3-1,030.0 -2.1%  
BALANCE SHEET DATA
Current assets Rs m24,5481,605 1,529.5%   
Current liabilities Rs m8,3771,022 819.6%   
Net working cap to sales %48.4492.1 9.8%  
Current ratio x2.91.6 186.6%  
Inventory Days Days421,402 3.0%  
Debtors Days Days11400 2.8%  
Net fixed assets Rs m19,259414 4,647.5%   
Share capital Rs m172145 118.1%   
"Free" reserves Rs m32,469816 3,978.7%   
Net worth Rs m32,640961 3,394.9%   
Long term debt Rs m160-   
Total assets Rs m43,8072,019 2,169.4%  
Interest coverage x90.2-181.1 -49.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.1 1,300.3%   
Return on assets %16.5-60.1 -27.5%  
Return on equity %21.8-126.9 -17.2%  
Return on capital %28.2-126.2 -22.3%  
Exports to sales %044.7 0.0%   
Imports to sales %0933.6 0.0%   
Exports (fob) Rs mNA53 0.0%   
Imports (cif) Rs mNA1,106 0.0%   
Fx inflow Rs m18,67853 35,275.2%   
Fx outflow Rs m3,6621,106 331.2%   
Net fx Rs m15,016-1,053 -1,426.2%   
CASH FLOW
From Operations Rs m5,620-1,275 -440.7%  
From Investments Rs m-741-222 333.3%  
From Financial Activity Rs m-4,6001,457 -315.8%  
Net Cashflow Rs m279-41 -684.7%  

Share Holding

Indian Promoters % 70.5 65.0 108.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.4 0.6 3,560.0%  
FIIs % 8.2 0.5 1,714.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 35.0 84.3%  
Shareholders   62,048 80,116 77.4%  
Pledged promoter(s) holding % 17.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on AJANTA PHARMA vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Suven Life Sciences Share Price Performance

Period AJANTA PHARMA Suven Life Sciences S&P BSE HEALTHCARE
1-Day 1.22% -0.32% -0.10%
1-Month -6.90% 3.61% -1.99%
1-Year -11.30% -30.60% -5.62%
3-Year CAGR 23.81% -37.98% 20.96%
5-Year CAGR 7.06% -19.91% 11.47%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of Suven Life Sciences the stake stands at 65.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.